Follicular lymphoma (FL) is a type of non-Hodgkin lymphoma (NHL) that arises from B-lymphocytes, a kind of white blood cell. It is considered an indolent (slow-growing) lymphoma, commonly affecting middle-aged and older adults. FL originates in lymph nodes but may also involve the bone marrow, spleen, or blood.
CAR-T Cell Therapy for Follicular Lymphoma
CAR-T cell therapy is an advanced immunotherapy used to treat relapsed or refractory follicular lymphoma (FL), particularly in patients who have failed at least two prior lines of treatment. It involves collecting a patient’s T-cells, genetically engineering them to express a chimeric antigen receptor (CAR) that targets the CD19 protein on B-cells, and reinfusing them to seek and destroy cancerous cells. CAR-T therapy, such as axicabtagene ciloleucel (Yescarta), has shown high response rates and durable remissions in FL, offering a promising option for patients with difficult-to-treat disease.
What the Package Includes
- Initial medical consultation and evaluation of eligibility
- Comprehensive diagnostic tests and staging assessments
- CAR-T cell collection, genetic modification, and preparation
- Hospital admission, infusion, and close monitoring during treatment
- Management of side effects such as cytokine release syndrome (CRS)
- Post-treatment follow-up and recovery support
- Multilingual patient coordination, interpretation, and case management
- Assistance with travel, local accommodations, and family support services
Why Choose China for CAR-T Therapy
China has emerged as a global leader in cell and gene therapy innovation, with the most number of on-going clinical trials and treatment programs approved and available ahead of many other countries. Patients benefit from:
- Early access to cutting-edge CAR-T therapies not yet widely available elsewhere
- Cost-effective treatment compared to the U.S. or Europe, without compromising quality
- Experienced medical teams specializing in lymphoma and immunotherapy
- Streamlined processes for international patients, coordinated by Medical Tourism China
Ideal Candidates
This package is designed for adult patients diagnosed with follicular lymphoma who have relapsed or failed to respond to standard therapies such as chemotherapy, targeted therapy, or stem cell transplantation. Each case is reviewed individually to ensure the highest chance of success.
Our Commitment
Medical Tourism China is dedicated to guiding patients through every step of their CAR-T journey. From initial inquiry to post-treatment recovery, we provide reliable information, professional coordination, and compassionate care.
